Nkongolo S, Nußbaum L, Lempp F, Wodrich H, Urban S, Ni Y. The retinoic acid receptor (RAR) α-specific agonist Am80 (tamibarotene) and other RAR agonists potently inhibit hepatitis B virus transcription from cccDNA. Antiviral Res. 2019;168:146-155 pubmed publisher

Seidensaal K, Nollert A, Feige A, Muller M, Fleming T, Gunkel N, et al. Impaired aldehyde dehydrogenase 1 subfamily member 2A-dependent retinoic acid signaling is related with a mesenchymal-like phenotype and an unfavorable prognosis of head and neck squamous cell carcinoma. Mol Cancer. 2015;14:204 pubmed publisher

Lauterbach A, Müller Goymann C. Comparison of rheological properties, follicular penetration, drug release, and permeation behavior of a novel topical drug delivery system and a conventional cream. Eur J Pharm Biopharm. 2014;88:614-24 pubmed

Weber F, Weinhofer I, Einwich A, Forss Petter S, Muneer Z, Maier H, et al. Evaluation of retinoids for induction of the redundant gene ABCD2 as an alternative treatment option in X-linked adrenoleukodystrophy. PLoS ONE. 2014;9:e103742 pubmed publisher

Scheinfeld N. Epiduo (adapalene 0.1% and benzoyl peroxide 2.5%) approval in children 9 years and older. Skinmed. 2013;11:295-6 pubmed

Murakami Y, Fukasawa M, Kaneko Y, Suzuki T, Wakita T, Fukazawa H. Retinoids and rexinoids inhibit hepatitis C virus independently of retinoid receptor signaling. Microbes Infect. 2014;16:114-22 pubmed publisher

Hayashi N, Kawashima M. Multicenter randomized controlled trial on combination therapy with 0.1% adapalene gel and oral antibiotics for acne vulgaris: comparison of the efficacy of adapalene gel alone and in combination with oral faropenem. J Dermatol. 2012;39:511-5 pubmed publisher

Keating G. Adapalene 0.1%/benzoyl peroxide 2.5% gel: a review of its use in the treatment of acne vulgaris in patients aged ≥ 12 years. Am J Clin Dermatol. 2011;12:407-20 pubmed publisher

Tan J. Adapalene 0.1% and benzoyl peroxide 2.5%: a novel combination for treatment of acne vulgaris. Skin Therapy Lett. 2009;14:4-5 pubmed

Irby C, Yentzer B, Feldman S. A review of adapalene in the treatment of acne vulgaris. J Adolesc Health. 2008;43:421-4 pubmed publisher

Abramovits W, Gupta A. Differin (adapalene) Gel, 0.3%. Skinmed. 2007;6:287-8 pubmed

Thiboutot D, Gollnick H. Treatment considerations for inflammatory acne: clinical evidence for adapalene 0.1% in combination therapies. J Drugs Dermatol. 2006;5:785-94 pubmed

Jain S. Topical tretinoin or adapalene in acne vulgaris: an overview. J Dermatolog Treat. 2004;15:200-7 pubmed

Waugh J, Noble S, Scott L. Spotlight on adapalene in acne vulgaris. Am J Clin Dermatol. 2004;5:369-71 pubmed

Waugh J, Noble S, Scott L. Adapalene: a review of its use in the treatment of acne vulgaris. Drugs. 2004;64:1465-78 pubmed

Czernielewski J, Michel S, Bouclier M, Baker M, Hensby J. Adapalene biochemistry and the evolution of a new topical retinoid for treatment of acne. J Eur Acad Dermatol Venereol. 2001;15 Suppl 3:5-12 pubmed

Wolf J. An update of recent clinical trials examining adapalene and acne. J Eur Acad Dermatol Venereol. 2001;15 Suppl 3:23-9 pubmed

Millikan L. Pivotal clinical trials of adapalene in the treatment of acne. J Eur Acad Dermatol Venereol. 2001;15 Suppl 3:19-22 pubmed

Millikan L. Adapalene: an update on newer comparative studies between the various retinoids. Int J Dermatol. 2000;39:784-8 pubmed

Kakita L. Tazarotene versus tretinoin or adapalene in the treatment of acne vulgaris. J Am Acad Dermatol. 2000;43:S51-4 pubmed

English J, Browne J, Halbach D. Effective treatment of localized Darier's disease with adapalene 0.1% gel. Cutis. 1999;63:227-30 pubmed

Petersen C. [Adapalene--a new retinoid receptor agonist for the treatment of acne vulgaris]. Ugeskr Laeger. 1998;160:6668-71 pubmed

Weiss J, Shavin J. Adapalene for the treatment of acne vulgaris. J Am Acad Dermatol. 1998;39:S50-4 pubmed

Shroot B. Pharmacodynamics and pharmacokinetics of topical adapalene. J Am Acad Dermatol. 1998;39:S17-24 pubmed

Shroot B, Michel S. Pharmacology and chemistry of adapalene. J Am Acad Dermatol. 1997;36:S96-103 pubmed

Brogden R, Goa K. Adapalene. A review of its pharmacological properties and clinical potential in the management of mild to moderate acne. Drugs. 1997;53:511-9 pubmed